More Sun Pharmaceutical Industries Limited news
Sun Pharmaceutical Industries LimitedNSE: SUNPHARMA

Press Release May 16 2025

May 16, 2025 at 5:47 PM EDT · Issued by Sun Pharmaceutical Industries Limited

Filed with NSE · May 16, 2025 at 5:47 PM EDT

On 6ix: 6ix.com/news/press-release-may-16-2025-1

Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated May 16, 2025

View Attachment

6ix hasn’t read this filing yet.

Sun Pharmaceutical Industries Limited on 6ix

Earlier from Sun Pharmaceutical Industries

  • Press Release May 12 2025May 12, 2025
  • Press Release May 08 2025May 8, 2025
  • Sun Pharma and Moebius Medical Announce Dual Publications on MM-II's Phase 2b Clinical Trial Results and Mechanism of Action in Osteoarthritis and CartilageApr 25, 2025
  • Press Release Apr 24 2025Apr 24, 2025
  • Press Release Apr 07 2025Apr 7, 2025

Later from Sun Pharmaceutical Industries

  • Press Release May 30 2025May 30, 2025
  • Press Release Jun 03 2025Jun 3, 2025
  • Pharmazz Inc. Secures $25 Million Strategic Equity Investment from Sun Pharmaceutical Industries Ltd.Jun 11, 2025
  • Sun Pharma appoints Kirti Ganorkar as the Managing Director, Dilip Shanghvi to continue as the Executive Chairman of the BoardJun 16, 2025
  • Press Release Jun 24 2025Jun 24, 2025
All Sun Pharmaceutical Industries news releases↗

Follow Sun Pharmaceutical Industries into a list and get an email when it puts out news.

Follow Sun Pharmaceutical Industries
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer